Microvisk Continuous Blood Donation Study

Clinical trial NCT06648837 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06648837
Sponsor: Microvisk Technologies Ltd
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pulmonary Embolism (Diagnosis)Deep Vein Thrombosis Atrial Fibrillation (AF)

Start date: 2025-01-13
Primary completion: 2029-10-30
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.